These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 17044774)
1. Mechanisms of curcumin- and EGF-receptor related protein (ERRP)-dependent growth inhibition of colon cancer cells. Reddy S; Rishi AK; Xu H; Levi E; Sarkar FH; Majumdar AP Nutr Cancer; 2006; 55(2):185-94. PubMed ID: 17044774 [TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor (EGFR)-related protein inhibits multiple members of the EGFR family in colon and breast cancer cells. Xu H; Yu Y; Marciniak D; Rishi AK; Sarkar FH; Kucuk O; Majumdar AP Mol Cancer Ther; 2005 Mar; 4(3):435-42. PubMed ID: 15767552 [TBL] [Abstract][Full Text] [Related]
3. Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R. Patel BB; Sengupta R; Qazi S; Vachhani H; Yu Y; Rishi AK; Majumdar AP Int J Cancer; 2008 Jan; 122(2):267-73. PubMed ID: 17918158 [TBL] [Abstract][Full Text] [Related]
4. Curcumin enhances dasatinib-induced inhibition of growth and transformation of colon cancer cells. Nautiyal J; Banerjee S; Kanwar SS; Yu Y; Patel BB; Sarkar FH; Majumdar AP Int J Cancer; 2011 Feb; 128(4):951-61. PubMed ID: 20473900 [TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor-related peptide inhibits growth of PC-3 prostate cancer cells. Marciniak DJ; Rishi AK; Sarkar FH; Majumdar AP Mol Cancer Ther; 2004 Dec; 3(12):1615-21. PubMed ID: 15634655 [TBL] [Abstract][Full Text] [Related]
6. Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R. Patel BB; Gupta D; Elliott AA; Sengupta V; Yu Y; Majumdar AP Anticancer Res; 2010 Feb; 30(2):319-25. PubMed ID: 20332435 [TBL] [Abstract][Full Text] [Related]
7. Curcumin synergizes with resveratrol to inhibit colon cancer. Majumdar AP; Banerjee S; Nautiyal J; Patel BB; Patel V; Du J; Yu Y; Elliott AA; Levi E; Sarkar FH Nutr Cancer; 2009; 61(4):544-53. PubMed ID: 19838927 [TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor-related protein inhibits cell growth and induces apoptosis of BxPC3 pancreatic cancer cells. Zhang Y; Banerjee S; Wang ZW; Marciniak DJ; Majumdar AP; Sarkar FH Cancer Res; 2005 May; 65(9):3877-82. PubMed ID: 15867387 [TBL] [Abstract][Full Text] [Related]
9. Curcumin synergizes the growth inhibitory properties of Indian toad (Bufo melanostictus Schneider) skin-derived factor (BM-ANF1) in HCT-116 colon cancer cells. Giri B; Gomes A; Sengupta R; Banerjee S; Nautiyal J; Sarkar FH; Majumdar AP Anticancer Res; 2009 Jan; 29(1):395-401. PubMed ID: 19331178 [TBL] [Abstract][Full Text] [Related]
10. Regression of early and intermediate stages of colon cancer by targeting multiple members of the EGFR family with EGFR-related protein. Schmelz EM; Xu H; Sengupta R; Du J; Banerjee S; Sarkar FH; Rishi AK; Majumdar AP Cancer Res; 2007 Jun; 67(11):5389-96. PubMed ID: 17545620 [TBL] [Abstract][Full Text] [Related]
11. EGF receptor-related protein (ERRP) inhibits invasion of colon cancer cells and tubule formation by endothelial cells in vitro. Rishi AK; Parikh R; Wali A; Durko L; Zhang L; Yu Y; Majumdar AP Anticancer Res; 2006; 26(2A):1029-37. PubMed ID: 16619503 [TBL] [Abstract][Full Text] [Related]
12. EGF-receptor related protein causes cell cycle arrest and induces apoptosis of colon cancer cells in vitro and in vivo. Levi E; Mohammad R; Kodali U; Marciniak D; Reddy S; Aboukameel A; Sarkar FH; Kucuk O; Rishi AK; Majumdar AP Anticancer Res; 2004; 24(5A):2885-91. PubMed ID: 15517892 [TBL] [Abstract][Full Text] [Related]
13. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Shimizu M; Deguchi A; Lim JT; Moriwaki H; Kopelovich L; Weinstein IB Clin Cancer Res; 2005 Apr; 11(7):2735-46. PubMed ID: 15814656 [TBL] [Abstract][Full Text] [Related]
14. Curcumin modulates the radiosensitivity of colorectal cancer cells by suppressing constitutive and inducible NF-kappaB activity. Sandur SK; Deorukhkar A; Pandey MK; Pabón AM; Shentu S; Guha S; Aggarwal BB; Krishnan S Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):534-42. PubMed ID: 19735878 [TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity and Apoptosis Effects of Curcumin Analogue (2E,6E)-2,6-Bis(2,3-Dimethoxybenzylidine) Cyclohexanone (DMCH) on Human Colon Cancer Cells HT29 and SW620 In Vitro. Rahim NFC; Hussin Y; Aziz MNM; Mohamad NE; Yeap SK; Masarudin MJ; Abdullah R; Akhtar MN; Alitheen NB Molecules; 2021 Feb; 26(5):. PubMed ID: 33652694 [TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of epidermal growth factor receptor-related protein is mediated by inactivation of ErbB receptors and nuclear factor-kappaB in pancreatic cancer. Zhang Y; Banerjee S; Wang Z; Xu H; Zhang L; Mohammad R; Aboukameel A; Adsay NV; Che M; Abbruzzese JL; Majumdar AP; Sarkar FH Cancer Res; 2006 Jan; 66(2):1025-32. PubMed ID: 16424038 [TBL] [Abstract][Full Text] [Related]
18. Akt is upstream and MAPKs are downstream of NF-κB in paclitaxel-induced survival signaling events, which are down-regulated by curcumin contributing to their synergism. Bava SV; Sreekanth CN; Thulasidasan AK; Anto NP; Cheriyan VT; Puliyappadamba VT; Menon SG; Ravichandran SD; Anto RJ Int J Biochem Cell Biol; 2011 Mar; 43(3):331-41. PubMed ID: 20883815 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Plummer SM; Holloway KA; Manson MM; Munks RJ; Kaptein A; Farrow S; Howells L Oncogene; 1999 Oct; 18(44):6013-20. PubMed ID: 10557090 [TBL] [Abstract][Full Text] [Related]
20. Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1. Chen A; Xu J; Johnson AC Oncogene; 2006 Jan; 25(2):278-87. PubMed ID: 16170359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]